http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2771638-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_931b512548a69538889978212d6104bb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 1998-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aeb0cd931b3cb6eab4f2c26f9604a88d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f43638d0a85be261421d012dcf9e1985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eb3e85a4a11ad458c087e198f5ea209
publicationDate 1999-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2771638-A1
titleOfInvention USE OF BISPHOSPHONATES IN THE PREPARATION OF PHARMACEUTICAL FORMS FOR INTRAMUSCULAR USE
abstract The present invention relates to the use of pharmaceutical substances of the bisphosphonate class in the preparation of pharmaceutical forms, intended to be administered intramuscularly for the treatment of pathologies of the skeletal system. The bisphosphonates which are to be used include, inter alia, the alendronic acid, clodronic acid, etidronic acid, medronic acid, pamidronic acid and their pharmacologically and pharmaceutically acceptable salts. The pharmaceutical forms in question are above all characterized by the presence of acid benzyl.
priorityDate 1997-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9511029-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0449405-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9528936-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33136
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517984
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6463
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2088
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411029050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407886524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449373544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408968722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16760285
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503883
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452540632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408184029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3305

Total number of triples: 45.